Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zomedica Pharmaceuticals Corp (NY: ZOM ) 0.1265 UNCHANGED Streaming Delayed Price Updated: 8:00 PM EDT, Aug 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Zomedica Pharmaceuticals Corp < Previous 1 2 3 4 Next > Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product August 29, 2024 Via ACCESSWIRE Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System August 22, 2024 Via ACCESSWIRE Zomedica Announces Key Educational Presentations at Fetch dvm360 Veterinary Conference August 20, 2024 Via ACCESSWIRE Zomedica Announces Second Quarter 2024 Financial Results: Revenue of $6.1 Million; 71% Gross Margin, and $83.0 Million in Liquidity to Support Growth August 14, 2024 Via ACCESSWIRE Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America August 14, 2024 Via ACCESSWIRE Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET August 01, 2024 Via ACCESSWIRE The United States Eventing Association Names Zomedica’s PulseVet(R) as the Official Shock Wave of the USEA July 17, 2024 Via ACCESSWIRE US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians July 01, 2024 Via ACCESSWIRE Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform June 27, 2024 Via ACCESSWIRE Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark June 25, 2024 Via ACCESSWIRE Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets July 09, 2024 Via ACCESSWIRE Sidoti Events, LLC's Virtual June Small-Cap Conference June 11, 2024 Via ACCESSWIRE Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024 June 10, 2024 Via ACCESSWIRE Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference June 06, 2024 Via ACCESSWIRE Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels June 04, 2024 Via ACCESSWIRE Zomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol Assay May 29, 2024 Via ACCESSWIRE Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy May 23, 2024 Via ACCESSWIRE Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform May 15, 2024 Via ACCESSWIRE Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity May 09, 2024 Via ACCESSWIRE Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 May 21, 2024 Via ACCESSWIRE Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024 May 08, 2024 Via ACCESSWIRE Zomedica Corp. (NYSE American: ZOM) Featured in Coverage of the EF Hutton Annual Global Conference May 06, 2024 Via Investor Brand Network Zomedica Expands International Reach with CE Certification for VetGuardian(R) System May 06, 2024 Via ACCESSWIRE Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform May 02, 2024 Via ACCESSWIRE Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET April 30, 2024 Via ACCESSWIRE Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024 April 09, 2024 Via ACCESSWIRE Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity April 01, 2024 Via ACCESSWIRE Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET March 20, 2024 Via ACCESSWIRE Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform March 14, 2024 Via ACCESSWIRE Zomedica Provides NYSE American Listing Update March 13, 2024 Via ACCESSWIRE < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.